Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA)
Titel:
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA)
Auteur:
Rusconi, S. Adorni, F. Tau, P. Borghi, V. Pecorari, M. Maserati, R. Francisci, D. Monno, L. Punzi, G. Meraviglia, P. Paolucci, S. Di Biagio, A. Bruzzone, B. Mancon, A. Micheli, V. Zazzi, M.